The 3+3 versus model-based approach: implementation in the CAPCISUM pancreatic cancer trial

Por Qian, Wendi, Mander, Adrian, Machin, Andrea, Dalchau, Katy, Corrie, Pippa
Publicado no Trials (2015)

Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised contro...

Por Falk, Stephen J, Girling, David J, White, Roger J, Hopwood, Penelope, Harvey, Angela, Qian, Wendi, Stephens, Richard J
Publicado em 2002

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY1...

Por Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.
Publicado em 2008

Speeding up the Evaluation of New Agents in Cancer

Por Parmar, Mahesh K. B., Barthel, Friederike. M.-S., Sydes, Matthew, Langley, Ruth, Kaplan, Rick, Eisenhauer, Elizabeth, Brady, Mark, James, Nicholas, Bookman, Michael A., Swart, Ann-Marie, Qian, Wendi, Royston, Patrick
Publicado em 2008

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective...

Por Parkinson, Christine A., Gale, Davina, Piskorz, Anna M., Biggs, Heather, Hodgkin, Charlotte, Addley, Helen, Freeman, Sue, Moyle, Penelope, Sala, Evis, Sayal, Karen, Hosking, Karen, Gounaris, Ioannis, Jimenez-Linan, Mercedes, Earl, Helena M., Qian, Wendi, Rosenfeld, Nitzan, Brenton, James D.
Publicado no PLoS Med (2016)

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 ran...

Por Stark, Dan, Nankivell, Matthew, Pujade-Lauraine, Eric, Kristensen, Gunnar, Elit, Lorraine, Stockler, Martin, Hilpert, Felix, Cervantes, Andrés, Brown, Julia, Lanceley, Anne, Velikova, Galina, Sabate, Eduardo, Pfisterer, Jacobus, Carey, Mark S, Beale, Philip, Qian, Wendi, Swart, Ann Marie, Oza, Amit, Perren, Tim
Publicado em 2013

Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial

Por Hancock, Barry W, Qian, Wendi, Linch, David, Delchier, Jean-Charles, Smith, Paul, Jakupovic, Ira, Burton, Cathy, Souhami, Robert, Wotherspoon, Andrew, Copie-Bergman, Christiane, Capella, Carlo, Traulle, Catherine, Levy, Michael, Cortelazzo, Sergio, Ferreri, Andres J M, Ambrosetti, Achille, Pinotti, Graziella, Martinelli, Giovanni, Vitolo, Umberto, Cavalli, Franco, Gisselbrecht, Christian, Zucca, Emanuele
Publicado em 2009

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

Por S. Ahmad, Saif, Qian, Wendi, Ellis, Sarah, Mason, Elaine, Khattak, Muhammad A., Gupta, Avinash, Shaw, Heather, Quinton, Amy, Kovarikova, Jarmila, Thillai, Kiruthikah, Rao, Ankit, Board, Ruth, Nobes, Jenny, Dalgleish, Angus, Grumett, Simon, Maraveyas, Anthony, Danson, Sarah, Talbot, Toby, Harries, Mark, Marples, Maria, Plummer, Ruth, Kumar, Satish, Nathan, Paul, Middleton, Mark R., Larkin, James, Lorigan, Paul, Wheater, Matthew, Ottensmeier, Christian H., Corrie, Pippa G.
Publicado no Melanoma Res (2015)